Viz.ai alternatives: 4 tools compared (October 2026)

Qure.ai develops AI software for medical imaging that reads chest X-rays, head CT scans and lung CT scans. It serves hospitals, imaging centers, public health programs and pharmaceutical companies, with a focus on tuberculosis, lung cancer and stroke.

Key functions

• qXR pre-reads chest X-rays and pre-fills reports
• qER flags suspected intracranial hemorrhage, mass effect, midline shift and cranial fracture on head CT
• qCT measures lung nodules and assigns malignancy risk based on Lung-RADS, Brock and Fleischner

Compared with Viz.ai

• Names fewer security certificates: 2, Viz.ai 9.
• Strong in the same markets as Viz.ai: United States.

Check before buying: In the US, check the cleared indications for each product, since FDA clearance differs by product and finding. In the UK, confirm the regulatory status of the exact product version and agree a data processing agreement under UK GDPR. Decide between cloud processing on Amazon Web Services or Azure and an on-premise installation, and ask for the cloud region. Pricing is only available on request.

Aidoc is a clinical AI platform for hospitals and radiology departments. It analyzes medical images in the background, flags urgent findings such as brain hemorrhage or pulmonary embolism, and routes them to the right care team.

Key functions

• Triage of CT and X-ray images for findings such as pulmonary embolism and brain hemorrhage
• aiOS runs in-house and partner algorithms on one platform connected to PACS and EHR
• CARE foundation model as the basis for clinical AI applications

Compared with Viz.ai

• Strong in the same markets as Viz.ai: United States.

Check before buying: Imaging studies are health data under Art. 9 GDPR and HIPAA. Aidoc names AWS and Azure but not the hosting regions, and its trust center could not be opened during our review, so request certifications and data residency details directly. Check which algorithms carry FDA clearance or a CE mark for your use, and keep radiologists responsible for every finding the triage flags or misses.

deepc is a Munich-based clinical AI infrastructure provider. Its deepcOS platform lets hospitals and radiology networks connect once to their systems and then deploy, monitor and govern AI applications from many vendors, including their own.

Key functions

• Runs commercial, in-house and agentic AI applications on a shared runtime
• Continuously monitors AI model performance and detects drift
• Drag-and-drop workflow builder with DICOM, HL7 and FHIR connectivity

Compared with Viz.ai

• Can store data in the EU; Viz.ai states no EU option.
• Headquartered in Germany, Viz.ai in United States.
• Names fewer security certificates: 3, Viz.ai 9.

Check before buying: deepcOS processes imaging and clinical documents, which are health data under Art. 9 GDPR. Clarify the hosting region, deployment model and DPA, since the public pages name regions but not cloud providers. The CE mark covers deepcOS AIDA; every third-party AI application on the platform needs its own conformity assessment. Plan who in radiology and IT reviews drift alerts and signs off new applications.

Lunit is a South Korean medical AI company for cancer screening and precision oncology. Its INSIGHT products support radiologists reading chest X-rays and mammograms, and its SCOPE suite analyzes pathology slides for research and drug development.

Key functions

• INSIGHT CXR detects eleven common chest X-ray abnormalities such as nodules and pneumothorax
• INSIGHT MMG scores 2D mammograms for malignancy and marks suspicious areas
• INSIGHT DBT highlights key slices in breast tomosynthesis

Compared with Viz.ai

• Names fewer security certificates: 1, Viz.ai 9.
• Strongest elsewhere: South Korea.

Check before buying: Images are health data under Art. 9 GDPR and HIPAA. For INSIGHT CXR, decide between on-premises and cloud deployment; in the cloud option a local gateway anonymizes data before it reaches Azure. Lunit notes that products are not available in all countries, so confirm the regulatory status for your market and product. Radiologists remain responsible for the final report.